We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
(+6.6%)
Cap. Flow
-$1.18B
Cap. Flow
% of AUM
-0.95%
Top 10 Holdings %
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applovin
APP
|
+$80.1M |
| 2 |
Chevron
CVX
|
+$75.4M |
| 3 |
Robinhood
HOOD
|
+$52.2M |
| 4 |
Nutanix
NTNX
|
+$32.2M |
| 5 |
Datadog
DDOG
|
+$29.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$166M |
| 2 |
Apple
AAPL
|
+$150M |
| 3 |
NVIDIA
NVDA
|
+$148M |
| 4 |
HES
Hess
HES
|
+$72.3M |
| 5 |
ANSS
Ansys
ANSS
|
+$59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.89% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 10.96% |
| 4 | Communication Services | 9.45% |
| 5 | Healthcare | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AARD
3251
Aardvark Therapeutics
AARD
$173M
| $75.8K | ﹤0.01% |
5,705
+216
| +4% | +$2.44K |
|
|
ALAR
3252
Alarum Technologies
ALAR
$14.3M
| $75K | ﹤0.01% |
5,022
-2,385
| -32% | -$34.4K |
|
3253
CSP Inc
CSPI
$82.1M
| $73.9K | ﹤0.01% |
6,395
-1,978
| -24% | -$23.2K |
|
3254
Gildan
GIL
$10.6B
| $73.3K | ﹤0.01% |
1,269
| – | – |
|
|
EEX
3255
DELISTED
Emerald Holding
EEX
| $73K | ﹤0.01% |
14,352
-4,674
| -25% | -$23.6K |
|
3256
CEMIG Preferred Shares
CIG
$6.01B
| $70.4K | ﹤0.01% |
33,366
-21,043
| -39% | -$41.3K |
|
3257
TriSalus Life Sciences
TLSI
$345M
| $69.9K | ﹤0.01% |
15,025
-1,438
| -9% | -$6.73K |
|
3258
Nerdy
NRDY
$96.7M
| $69.5K | ﹤0.01% |
55,188
-4,980
| -8% | -$7.12K |
|
3259
Nuvectis Pharma
NVCT
$617M
| $68.2K | ﹤0.01% |
11,330
-1,348
| -11% | -$9.27K |
|
|
DRD
3260
DRDGold
DRD
$2.05B
| $68.2K | ﹤0.01% |
2,471
| – | – |
|
|
NNDM
3261
Nano Dimension
NNDM
$343M
| $68.1K | ﹤0.01% |
43,370
-3,490
| -7% | -$5.09K |
|
|
SWKH
3262
DELISTED
SWK Holdings
SWKH
| $67.2K | ﹤0.01% |
4,620
-132
| -3% | -$1.95K |
|
3263
Lucid Diagnostics
LUCD
$184M
| $66.8K | ﹤0.01% |
66,129
+3,113
| +5% | +$3.4K |
|
3264
Bilibili
BILI
$7.84B
| $65.8K | ﹤0.01% |
2,342
-270
| -10% | -$6.47K |
|
3265
Value Line
VALU
$361M
| $65.2K | ﹤0.01% |
1,669
+53
| +3% | +$2.03K |
|
3266
WPP
WPP
$5.94B
| $65K | ﹤0.01% |
2,594
-2,066
| -44% | -$56.4K |
|
|
BESI
3267
DELISTED
BE SEMICONDCTR INDS NV NY REGS
BESI
| $64.8K | ﹤0.01% |
435
| – | – |
|
|
GRVY
3268
GRAVITY
GRVY
$473M
| $64.1K | ﹤0.01% |
1,002
-243
| -20% | -$15.6K |
|
3269
Pro-Dex
PDEX
$209M
| $64.1K | ﹤0.01% |
1,893
-352
| -16% | -$15.1K |
|
|
SDX
3270
DELISTED
SODEXHO ALLIANCE SA ADS (REP 1 COM SHR)
SDX
| $63.7K | ﹤0.01% |
5,035
| – | – |
|
3271
SKYX Platforms
SKYX
$164M
| $63.7K | ﹤0.01% |
56,887
-203
| -0.4% | -$230 |
|
|
VRNA
3272
DELISTED
Verona Pharma
VRNA
| $63.6K | ﹤0.01% |
596
+84
| +16% | +$8.77K |
|
|
NVA
3273
Nova Minerals Corp
NVA
$218M
| $63.2K | ﹤0.01% |
+19,270
| New | +$45.5K |
|
|
ZK
3274
DELISTED
Zeekr
ZK
| $63.2K | ﹤0.01% |
2,073
+860
| +71% | +$24.9K |
|
|
TMIC
3275
DELISTED
TREND MICRO INC SPONS ADR-NEW
TMIC
| $63K | ﹤0.01% |
1,150
+205
| +22% | +$11.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2025 Portfolio in Review
As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
- RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
- RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
- RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
- RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
- RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
- RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
- RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.
Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.